Megan Berg

Megan Reddington Berg is a highly experienced professional in the pharmaceutical industry, currently serving as the Director of Trial Initiation for Oncology at Merck. With a Bachelor of Science in Business Administration from Rider University and a mini-MBA Certification from Rutgers University, they have successfully managed multiple projects, emphasizing flawless execution and adherence to timelines. Previously, Megan specialized in contracts management and systems training at organizations such as PRA Health Sciences, ReSearch Pharmaceutical Services, and Hoffmann-La Roche, developing strong working relationships across various teams. Recognized for their energetic and goal-oriented approach, Megan possesses extensive expertise in contract drafting, negotiation, and budget management.